Sign In
Buy CLOV
$3.65
-0.0800 (-2.14%)
At Close: Jun 03, 2026
Watch These 3 MedTech Stocks for Q1 Earnings: Beat or Miss?
12:10pm, Monday, 05'th May 2025
MedTech companies' quarterly results are likely to reflect strength in customer demand. Let's see how FMS, MASI and CLOV are placed ahead of their earnings releases.
New whitepaper highlights how a relationship with a Primary Care Physician (“PCP”) that uses Counterpart Assistant is associated with better clinical management, and fewer hospitalizations (18% lo
Clover Health Announces Changes to Board of Directors
05:00pm, Tuesday, 22'nd Apr 2025
Thomas L. Tran will become Chairman of the Audit Committee and the Nominating and Corporate Governance Committee, and Lee A. Shapiro will not stand for re-election at the 2025 Annual Shareholders' Mee
Clover Health to Participate in Upcoming Investor Conferences
04:05pm, Monday, 21'st Apr 2025
WILMINGTON, Del., April 21, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced its participation in the
Clover Health to Report First Quarter 2025 Financial Results on May 6, 2025
04:05pm, Tuesday, 08'th Apr 2025
WILMINGTON, Del., April 08, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that it will report first
Clover Health Appoints Industry Veteran as Chief Medical Officer of Medicare Advantage
04:05pm, Monday, 07'th Apr 2025
Dr. Shelly Gupta Brings Over a Decade of Medicare Advantage and Healthcare Leadership Experience Dr. Shelly Gupta Brings Over a Decade of Medicare Advantage and Healthcare Leadership Experience
Clover Health: Expected Margin Contraction Is A Prelude To Exponential Growth
07:45am, Friday, 07'th Mar 2025
Clover Health Investments' AI capabilities are a major driver for its topline and bottom-line improvements in FY 2024. Clover Health's MCR in Q4 represented a decline from Q3, unlike past years, and r
Missed the Hims & Hers Rally? Clover Health Could Be Next
07:24am, Wednesday, 05'th Mar 2025
Shares of Hims & Hers Health Inc. NYSE: HIMS have made a splash in recent weeks, reaching a new all-time high of just under $73 per share. However, a few days later, most of the upside moved right ba
Counterpart Health Partners with Google Cloud to Improve Clinical Data Access for Physicians
09:00am, Monday, 03'rd Mar 2025
New functionality within Counterpart Assistant uses Google Cloud's Vertex AI Search to give clinicians comprehensive insights across multiple sources of patient health data New functionality within Co
CLOV Q4 Earnings Beat Estimates, Sales Miss, Membership Rises
10:40am, Friday, 28'th Feb 2025
Clover Health's fourth-quarter 2024 results continue to benefit from the strength of its strong member retention. Strong revenue outlook bodes well.
Clover Health Investments, Corp. (CLOV) Q4 2024 Earnings Call Transcript
07:32pm, Thursday, 27'th Feb 2025
Clover Health Investments, Corp. (NASDAQ:CLOV ) Q4 2024 Earnings Conference Call February 27, 2025 5:00 PM ET Company Participants Ryan Schmidt - Investor Relations Andrew Toy - Chief Executive Office
Clover Health Investments, Corp. (CLOV) Tops Q4 Earnings Estimates
07:30pm, Thursday, 27'th Feb 2025
Clover Health Investments, Corp. (CLOV) came out with quarterly earnings of $0.02 per share, beating the Zacks Consensus Estimate of a loss of $0.07 per share. This compares to loss of $0.12 per share
Clover Health Reports Fourth Quarter and Full Year 2024 Results; Provides Full Year 2025 Guidance
04:05pm, Thursday, 27'th Feb 2025
Full year 2024 GAAP Net loss from continuing operations improves by $164 million year-over-year Full year 2024 Adjusted EBITDA of $70 million, representing an increase of $112 million year-over-yea
Clover Health to Participate in Upcoming Investor Conferences
04:05pm, Monday, 24'th Feb 2025
WILMINGTON, Del., Feb. 24, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover Health”), today announced its participation in the following investor conferences: CFO,
Clover Health to Report Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025
04:05pm, Tuesday, 18'th Feb 2025
WILMINGTON, Del., Feb. 18, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover Health”), today announced that it will report fourth quarter and full year 2024 financi
